Viewing Study NCT00103259


Ignite Creation Date: 2025-12-24 @ 3:00 PM
Ignite Modification Date: 2026-01-02 @ 3:14 AM
Study NCT ID: NCT00103259
Status: COMPLETED
Last Update Posted: 2014-05-23
First Post: 2005-02-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Sponsor: National Cancer Institute (NCI)
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2005-07
Start Date Type: None
Primary Completion Date: 2011-11
Primary Completion Date Type: ACTUAL
Completion Date: 2011-11
Completion Date Type: ACTUAL
First Submit Date: 2005-02-07
First Submit QC Date: None
Study First Post Date: 2005-02-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2012-11-24
Results First Submit QC Date: None
Results First Post Date: 2012-12-27
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2014-05-07
Last Update Post Date: 2014-05-23
Last Update Post Date Type: ESTIMATED